Member Info for ratcliffewriter

How awful for you to think that my molecular remains will eventually be part of Uranus.

Aimbig being one of the most enthusiastic among them I believe - 'crackin one off all the time' so they say.

I wonder if the discussions about figures could be conducted elsewhere, because it is a little tedious for those not involved. Or maybe over on advfn where I believe there are some top class maths debaters.

And for dessert, a fruit bat!

It will be entirely voluntary for military personnel if they want their families to eat this winter, and if there are any nasty side effects they will try it on the moslem minority with the explanation that if they take the vaccine it will stop them from dying....at least that day...

Substantially oversubscribed in fact.

Those who would say crackin is a wit would be half right.

Thanks for that extra Bermuda- I had a feeling the first collaboration was European based but couldn't remember where it was detailed. Still, global companies have to have a base somewhere. Europe, America, or even China....

The rns on the first collaboration made no mention of a country or area, it was only the second and third that were named as Chinese and American. So the first could reasonably 'global', but then so could either of the others. I doubt scancell are likely to say 'global' unless they mean just that however, because it will all come out in any announcement.

Just checking a few facts after my post about the comment scancell are in ‘advanced commercial discussions’ around Avidimab - the first collaboration and non-exclusive research agreement is with ‘a leading antibody technology company’ and was announce on 4th September last year. The first anniversary is up in a fortnight. The second agreement was in December with a Chinese company, and the third in January this year with an American company. Here’s hoping the anniversary brings some good news with it!

Coca cola still advertise, so publicity never hurts Insupposr. Keeps you in the spotlight.

Don't forget what was said in the rns announcing the placing regarding Avidimab (and I cut and paste here for accuracy) - 'Advanced commercial discussions are currently underway with a global biotech with initial commercial collaboration potentially to be in the form of granting a partner an option to a future licence.'

It would command a stiff price for sure.

'talking about politics on here is probably not a good idea' - followed by a lengthy political post. Could we have a bit more stuff focused on Scancell please? The company is in an unprecedentedly strong position in general, but I doubt the Marxist enclaves of Islington are saying much about us, so let's leave them off here by return.

What was that line in the recent RNS? 'Advanced commercial discussions.' Hmm....

Oh dear - as soon as you see the words 'the astute' (especially with some capital letters) you know exactly what's going on. An 'ass toot' has crawled under the fence and returned despite being banned under his previous identity. A pity when there is so much good stuff looming here, and a new high profile high quality investor taking a stake. Let's see what happens over coming weeks and months and try not to let the ass toots cause too much wilful disruption with half truths and pompous lies.

Good point - that's fair enough then. Lightens my mood considerably as I was just off to the shed for a pint of paraquat after reading Crackin's observations.

That's well and truly oversubscribed then.

Lindy's full entitlement would have cost 44,000 quid, and given that she has just taken a 25 percent pay cut and we are not privy to her personal financial situation, I would guess a lot depends on how much spare cash she has tucked under the mattress at this precise moment.

I suspect crackin is actually more disappointed that any of the directors actually did buy shares.